We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in GreenLight Biosciences Holdings, PBC Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

20.16% less ownership

Funds ownership: 20.16% → 0% (-20%)

100% less funds holding

Funds holding: 48 → 0 (-48)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $9.16M → $0 (-$9.16M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 48

Holders
–
Holders Change
-48
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
48
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$2.74M
2
CGC
Continental Grain Company
New York
-$1.95M
3
TCM
Tao Capital Management
California
-$802K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$513K
5
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$503K

GRNA Hedge Fund Activity: Q3 2023 in Review

0 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q3 2023, worth a combined $0 — down 100% from $9.16M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of GRNA and 0 opened new positions — a net loss of 48 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cormorant Asset Management, exiting entirely with an estimated $2.74M sold.

  • 0 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q3 2023, down from 48 in Q2 2023.
  • Funds reported $0 of GreenLight Biosciences Holdings, PBC Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q3 2023 and 48 closed out, a net change of -48 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q3 2023 was Cormorant Asset Management, an estimated $2.74M sold.

Based on aggregated 13F filings for Q3 2023.